Stay updated with breaking news from Nasdaq Grcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gracell Biotechnologies (NASDAQ:GRCL – Get Free Report) and Evolva (OTCMKTS:ELVAF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Insider & Institutional Ownership 22.0% of Evolva shares are […]
Piper Sandler reissued their neutral rating on shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $10.00 target price on the stock. A number of other research analysts also recently commented on the company. Citigroup lowered their target price […]
HC Wainwright lowered shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) from a buy rating to a neutral rating in a report released on Tuesday morning, MarketBeat reports. The firm currently has $10.00 target price on the stock, down from their prior target price of $13.00. HC Wainwright also issued estimates for Gracell Biotechnologies’ FY2026 […]
HC Wainwright lowered shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat.com reports. HC Wainwright currently has $10.00 target price on the stock, down from their previous target price of $13.00. HC Wainwright also issued estimates for Gracell […]
Gracell Biotechnologies (NASDAQ:GRCL – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at Piper Sandler in a report issued on Wednesday, Benzinga reports. They currently have a $10.00 target price on the stock. Piper Sandler’s price objective points to a potential upside of 0.81% from the company’s previous close. A number of […]